Ovarian cancer (OvCa) is characterized by widespread and rapid metastasis in the peritoneal cavity. Visceral adipocytes promote this process by providing fatty acids (FAs) for tumour growth. However, the exact mechanism of FA transfer from adipocytes to cancer cells remains unknown. This study shows that OvCa cells co-cultured with primary human omental adipocytes express high levels of the FA receptor, CD36, in the plasma membrane, thereby facilitating exogenous FA uptake. Depriving OvCa cells of adipocyte-derived FAs using CD36 inhibitors and short hairpin RNA knockdown prevented development of the adipocyte-induced malignant phenotype. Specifically, inhibition of CD36 attenuated adipocyte-induced cholesterol and lipid droplet accumulation and reduced intracellular reactive oxygen species (ROS) content. Metabolic analysis suggested that CD36 plays an essential role in the bioenergetic adaptation of OvCa cells in the adipocyte-rich microenvironment and governs their metabolic plasticity. Furthermore, the absence of CD36 affected cellular processes that play a causal role in peritoneal dissemination, including adhesion, invasion, migration and anchorage independent growth. Intraperitoneal injection of CD36-deficient cells or treatment with an anti-CD36 monoclonal antibody reduced tumour burden in mouse xenografts. Moreover, a matched cohort of primary and metastatic human ovarian tumours showed upregulation of CD36 in the metastatic tissues, a finding confirmed in three public gene expression data sets. These results suggest that omental adipocytes reprogram tumour metabolism through the upregulation of CD36 in OvCa cells. Targeting the stromaltumour metabolic interface via CD36 inhibition may prove to be an effective treatment strategy against OvCa metastasis.
Introduction
Unlike most solid tumours, ovarian cancer (OvCa) disseminates widely in the peritoneal cavity before giving rise to hematogenous or lymphatic metastasis. The rapid and clinically silent spread of OvCa has been attributed to the unique mechanism of transcoelomic metastasis, which ultimately involves attachment and growth of tumour cells on peritoneum-covered abdominal organs [1] [2] [3] . Tumourous transformation of the omentum, a peritoneal apron-like organ, predominantly composed of adipocytes, is a hallmark of advanced stage OvCa [4] . The omental metastasis is often the biggest tumour, larger than tumours in the ovary or the fallopian tube [5] , which are currently considered to be the organs of origin for ovarian cancer [6, 7] . Previously, our group showed that adipocytes promote OvCa growth through the provision of fatty acids (FAs) [8] [9] [10] . However, the exact mechanism through which adipocyte-derived FAs are transported into OvCa cells and whether interference with FA trafficking can halt tumour progression remains unknown.
FAs are translocated across the phospholipid bilayers of the plasma membrane through either passive diffusion or a saturable protein-mediated transport system. Several membrane-associated FA binding proteins and transporters reportedly facilitate the transport process, including CD36 (also known as FA translocase [FAT] ), FATPs (Fatty Acid Transport Protein Family) and FABPpm (Plasma Membrane Fatty Acid Binding Protein). CD36, a transmembrane glycoprotein that belongs to the class B scavenger receptor family, is one of the most well-characterized members of this group [11] . In addition to FA uptake, CD36 facilitates cholesterol uptake and transduces intracellular signalling that regulates the metabolic targeting of FAs [12] . CD36 has also been implicated in other important cellular functions pertaining to tumour biology, including antigen presentation, inflammation, angiogenesis and cell adhesion (reviewed in refs. [12, 13] ).
Although tissue-specific expression of the FA transporters has been described in FA-utilizing organs, less is known about the expression profile of these receptors in cancerous tissues and the role of the tumour microenvironment in their distribution [14] . Our objective in this study was to determine which FA receptors in the adipocyte-rich tumour microenvironment are involved in transporting FAs inside the OvCa cells and whether these receptors play a wider role in OvCa metastasis.
Results

Omental adipocytes induce expression of CD36
To identify the effect of human primary adipocytes (HPAs) on FA transporter expression and distribution, we studied a panel of OvCa cell lines [15] with immunoblotting and immunofluorescence microscopy. We found that, except for CD36 ( Fig. 1a) , the most prevalent FA transporters (FABPpm, FATP1 and FATP4) [16, 17] were unaffected by HPA co-culturing ( Fig. 1b, c) . The mutational status of p53, a regulator of lipid metabolism pathways [18] , and cellular immortalization had no effect on adipocyte-induced CD36 over-expression ( Supplementary Figure S1a and S1b). HPA co-culture increased CD36 protein levels in cancer cells over time with maximum levels reaching in 24−48 h ( Fig.  1a, Supplementary Figure S1c ). Quantitative real-time reverse transcription-PCR (qRT-PCR) showed increased CD36 mRNA levels in all three OvCa cell lines in the presence of HPA (Supplementary Figure S1d ). CD36 expression in OvCa cells was localized to the plasma membrane, as demonstrated by cellular fractionation (Fig.  1d, Supplementary Figure S1e ) and confocal microscopy ( Fig. 2a, Supplementary Video 1) . It was apparent that the induction of CD36 was specific to adipocytes because other stromal cell types (fibroblast, mesothelial cells, macrophages) in the omentum did not induce CD36 expression (data not shown).
CD36 expression is associated with increased fatty acid uptake and lipid accumulation
The induction of CD36 at the plasma membrane upon HPA co-culture ( Fig. 2a ) coincided with increased cellular FA uptake as measured using a fluorescently labelled FA analogue ( Fig. 2b ). Adipocyte-conditioned media (CM) stimulated a significant increase in FA uptake in SKOV3ip1 cells, which was suppressed by the CD36 inhibitor [19] , sulfo-N-succinimidyl oleate (SSO) ( Fig. 2b) .
To investigate the impact of CD36 inhibition on metabolic and tumourigenic properties of OvCa cells, we generated stable populations of SKOV3ip1 cells expressing lentivirus-derived short hairpin RNA (shRNA) targeting CD36. The selected CD36 shRNA silenced both constitutive and adipocyte-induced CD36 expression (Supplementary Figure S2a , b). The proliferation and viability rates of the altered SKOV3ip1 cells were comparable to the parental control (Supplementary Figure S2c, d ). Abrogation of CD36 expression in SKOV3ip1 cells using an shRNA led to lower basal and adipocyte CM-induced FA uptake ( Fig. 2c ). Reduced CD36 expression and consequent reduced FA uptake resulted in lower lipid droplet (LD) accumulation, as shown using immunofluorescent staining for neutral lipids (Fig. 2d ). Collectively, these results point to a role for CD36 in adipocyte-induced FA uptake and lipid accumulation in OvCa cells.
Omental adipocyte-induced gene expression signature is associated with CD36 functions
To understand the molecular mechanisms leading to CD36 activation in OvCa cells and to identify pathways behind the observed metabolic changes with adipocyte stimulation, we performed an unbiased global gene expression analysis. HPA co-culturing altered 502 differentially expressed genes (DEG) in SKOV3ip1 cells; of these, 278 and 224 genes were up-and downregulated, respectively. The top up-and downregulated genes are shown in Table 1 Table 2 and Supplementary  Table S1 ) [8, 9] . We found that genes regulating global lipid metabolism and cholesterol synthesis were strongly inhibited ( Fig. 3a, b , Supplementary Table S2 ). Two important hubs in this network include the downregulation of Acetyl-CoA [20] , and the upregulation of nuclear factor-kappa B (NFκB), a crucial player in cancer metastasis and oxidative stress (Fig. 3b ) [21] . Transcription factor analysis revealed that key regulators of lipogenic genes, including the Sterol Regulatory Element Binding Transcription Factors (SREBPF1 and SREBPF2), were strongly inhibited by HPA stimulation ( Supplementary Table S2 ), whereas transcription factors (e.g., STAT1, HIF-1α, FOXO1 and PPARγ coactivator-related 1) known to be involved in the regulation of CD36 activation and plasma membrane recruitment were activated [2, 22, 23] . In summary, we observed an overlap between the adipocyte-induced transcriptional gene signature characterized by the induction of proinflammatory cytokine secretion, oxidative stress, enrichment of pathways affecting lipid and cholesterol synthesis, and the previously reported signalling pathways downstream of CD36 [24] [25] [26] .
Cellular energy homeostasis, intra-cellular cholesterol and ROS content are regulated by CD36
The response to increased energy needs in muscle tissue is coordinated by the interaction of AMP-activated protein kinase (AMPK) and CD36 [27] . We had previously shown that AMPK is activated in OvCa cells with HPA co-culture [8] . In this study, we observed a very robust increase in p-AMPK when CD36 shRNA cells were co-cultured with HPA ( Fig. 4a ). This suggests that while CD36 expression suppresses AMPK activation in OvCa cells in a similar manner to the process observed in muscle cells, exogenous FAs can acutely activate AMPK in both a CD36 dependent and independent fashion [27] .
Next, we determined the bioenergetic profile of CD36 wild-type and deficient OvCa cancer cells in response to HPA co-culture. Extracellular acidification rate (ECAR) increased in response to adipocyte CM in both parental and knockdown cells. However, glycolytic rate and maximum glycolytic capacity were impaired in the CD36 shRNA cells (Fig. 4b ). Inhibition of CD36 led to higher levels of both basal and maximal mitochondrial respiration, as indicated by the increased oxygen consumption rate (OCR) (Fig. 4c ). These data suggest that in tumour cells, CD36 expression, in addition to enhancing FA uptake, enhances anaerobic glucose metabolism while suppressing glucose oxidation.
Following up on the major pathways identified by the microarray analysis, we measured the effect of HPA stimulation on intracellular cholesterol content. At baseline, we found no statistically significant difference between total cellular cholesterol levels in parental and CD36 shRNA cells. Upon adipocyte stimulation, intracellular cholesterol content increased significantly, but was abrogated in the CD36 shRNA cells (p < 0.01) ( Fig. 4d ). These data, together with evidence of the downregulation of genes of lipid and cholesterol synthesis, are consistent with the concept that CD36 expression in tumour cells shifts metabolism from production of endogenous lipids to reliance on exogenous FA and cholesterol. Previously reported data in other model systems have shown that CD36 can regulate inflammatory mediators and reactive oxygen species (ROS) [28, 29] . We therefore investigated whether adipocyteinduced lipid influx results in CD36-mediated lipotoxicity [30] . For this purpose, we utilized the thiobarbituric acidreactive (TBAR) assay, which measures malondialdehyde (MDA), a product of lipid peroxidation and an indicator of ROS. HPA co-culture increased the generation of TBARs in wild-type CD36 cells by 81%, while CD36shRNA cells showed a more modest 29% increase in response to HPA (p < 0.01) ( Fig. 4e ).
CD36 regulates in vitro tumourigenicity and in vivo metastasis
Before it was thought of as an FA transporter, CD36 was identified as a glycoprotein receptor (glycoprotein IIIB/IV) for thrombospondin-1 (TSP-1) [31] , and collagen [32] . As such, it was found to be involved in cellular migration and adhesion in a variety of cell types. In our model system, inhibition of CD36 expression significantly reduced both baseline and adipocyte-stimulated invasion and migration ( Fig. 5a ), as well as adhesion of OvCa cells to two (type I collagen: 51% and laminin: 39%, p < 0.01) of the most Fig. 2 Inhibition of CD36 reduces adipocyte-induced fatty acid uptake and lipid accumulation. a Confocal immunofluorescence microscopy to detect CD36. SKOV3ip1 cells were cultured alone or with HPA for the indicated times and fixed on glass coverslips followed by incubation with a CD36 primary antibody and an Alexa-488-conjugated secondary antibody (green). Nuclei were counterstained with Hoechst 33258 (blue). Scale bars, 10 µm. b, c Effects of adipocyte conditioned media (CM) and the CD36-specific inhibitor Sulfo-N-Succinimidyl Oleate (SSO) on parental (SKOV3ip1), scramble control (SKOV3ip1 shRNA-Scramble) and CD36 shRNA transduced cells (SKOV3ip1 shRNA-CD36) over time. Cancer cells (2.5×10 5 ) were serum-starved and when indicated incubated with adipocyte-CM and/ or the irreversible CD36 inhibitor, SSO. FA transport was measured with a fluorescently labelled fatty acid (BODIPY-FA) and a nontoxic cell-impermeable quenching agent (Q-Red.1) at the indicated time points. Exclusion of the quenching reagent from the cells results in an increase in fluorescent signal intensity originating from intracellular BODIPY-FA. Changes in intracellular FA levels are quantified with a fluorescent plate reader as described in the materials and methods. ***p < 0.001. d Intracellular lipid accumulation in parental (SKO-V3ip1), scramble control (SKOV3ip1 shRNA-Scramble) and CD36 shRNA transduced cells (SKOV3ip1 shRNA-CD36) cultured with HPA. After 16 h of co-culturing, neutral lipid droplets (LD) were stained with BODIPY 493/503 and total LD area was calculated with ImageJ. Bars represent the mean ± s.e.m. from three independent experiments (n.s. not significant, **p < 0.01) Representative immunofluorescent images of cellular LD accumulation (LD in green, BODIPY 493/503 and nuclei in blue, Hoechst 33258) are shown common extracellular matrix components of the peritoneum (Fig. 5b ) [33] . Furthermore, silencing CD36 expression resulted in significantly fewer colonies (142 vs. 27, p < 0.01) in a soft agar assay ( Fig. 5c ).
To understand the in vivo tumourigenic potential of CD36-deficient cancer cells we injected shRNA-mediated CD36 knockdown cells intraperitoneally into female athymic BALB/c nude mice. Animals injected with CD36 shRNA cells developed significantly smaller (tumour weight: 0.12 vs. 1.19 g, p < 0.01) and fewer tumours (number of metastatic nodules: 18 vs. 188, p < 0.001) compared to scrambled shRNA controls ( Fig. 6a ). In order to further assess the possible therapeutic utility of CD36inhibition, another set of mice was treated with daily intraperitoneal injections of a functionally neutralizing anti-CD36 antibody or its isotype control [34] . We again observed a significant reduction in tumour burden (tumour weight: 1.12 vs. 0.63 g, p < 0.01 and number of metastatic nodules: 164 vs. 104, p < 0.01, Fig. 6b ). We also tested the anti-tumour activity of the specific CD36 inhibitor, SSO, and observed a modest tumour reduction. However, in contrast to prior reports [35, 36] , we observed significant in vivo toxicity (data not shown).
The histologies of the xenograft tumours were similar on hematoxylin and eosin (H&E) staining (Supplementary Figure S4a ). The differential growth rate was not caused by reduced proliferation and/or increased apoptosis as staining of excised tumour nodules with the proliferation marker (Ki-67) and TUNEL assay were not significantly different (Supplementary Figure S4a ). The absence of CD36 was accompanied by a reduction in microvessel density (MVD) observed in both SKOV3ip1 and OVCAR8 xenograft mouse models (Supplementary Figure S4a and S4b). However, reduced MVD was not associated with increased intra-tumoural hypoxia as indicated by low indexes of the endogenous surrogate marker CA IX ( Supplementary Figure S4c). Extracellular matrix deposition, assayed by automated image analysis after fibronectin immunostaining (Supplementary Figure S4d) and Masson's Trichrome staining (Supplementary Figure S4e ) were found to be comparable between control and CD36 antibody-treated tumours. Table S3 ). To obtain a homogenous cancer cell population, tissues were laser micro-dissected (Supplementary Figure S5a ) followed by the assessment of CD36 mRNA expression. In seven of the ten samples evaluated, CD36 expression increased in the metastatic samples when compared to their PT counterparts (p < 0.05, Wilcoxon signed rank test, Fig. 7a ). Using the Oncomine expression analysis tool, we validated these findings in three publically available data sets [37] [38] [39] that provided matched quantitative gene expression data from human PT and either omental or peritoneal metastasis (OM) samples ( Fig. 7b ). Consistent with the in vitro, in vivo and ex vivo experiments, a significant upregulation of CD36 was observed in all three data sets (***p < 0.001). Survival analysis revealed that high CD36 expression is associated with reduced progression-free and overall survival ( Supplementary Figure S5b ).
Discussion
A recently described hallmark of cancer metabolism is the ability of cancer cells to acquire nutrients from the tumour microenvironment [40] . Our previous work showed that OvCa cells obtain FA from surrounding adipocytes [8, 9] , while Kamphorst et al. found that, through oncogenic signalling, hypoxic tumour cells could increase their FA import by scavenging FAs from serum phospholipids [41] . Furthermore, several murine models combining in vitro, ex vivo and in vivo studies suggested that, in obesity, enhanced vascularity and lipid transport increase the metastatic success of OvCa [42] . However, none of these studies, which describe the cellular effects of external lipid acquisition on cancer cells, have elucidated the exact mechanism(s) for lipid transport.
Here we report that lipids are transported into OvCa cells through CD36, an integral membrane FA receptor. Omental adipocytes induce CD36 expression on cancer cells and subsequently FA uptake. The mechanism described is very similar to the physiologic process involved in peripheral FA acquisition in muscle and adipose tissues, which strongly relies on CD36. Consequently, CD36 knockout mice have defective FA uptake in myocardial, skeletal muscle and adipose tissue, and impaired triglyceride synthesis [43] . Despite its role in enhancing FA uptake, CD36 is not absolutely required for the process [12] . FAs from adipocytes can diffuse across the plasma membrane, although passive uptake is inefficient in meeting the FA requirement of most tissues, most likely because it is not coupled with metabolic targeting [44] .
Our findings suggest that omental adipocytes alter tumour metabolism to accommodate exogenous supplies of FA and cholesterol and that induction of CD36 on tumour cells is important for this metabolic remodelling. CD36 expression reduces glucose oxidation by tumour cells and shifts metabolism to reliance on the uptake and storage of exogenous lipids while endogenous lipid synthesis is inhibited ( Fig. 3a and Supplementary Table S2 ). CD36-mediated FA uptake is a likely factor in the inhibition of oxidative glucose metabolism [45] , while modulation of PGC-1 signalling by CD36 might play a role in inhibition of cholesterol biosynthesis [46] . CD36 interaction with the lipogenic pathway was noted in mice with stearoyl-CoA desaturase-1 (SCD1) deficiency and is consistent with cross regulation between FA uptake and FA synthesis [47] .
Co-culture with adipocytes not only induced CD36 expression, but also led to a substantial increase in the number and size of LDs and intracellular cholesterol content. A number of recent studies in various solid tumours have recognized LDs, the storage sites of excessive lipids and cholesterol, as functional organelles that influence tumour growth, aggressiveness and chemotherapy response [48] [49] [50] . Conversely, we show that loss of CD36 expression confers protection from adipocyte-induced LD accumulation and reduces oxidative stress.
Our finding of overexpression of CD36 mRNA in omental metastasis samples is in accordance with a recent report showing that the CD36 protein is more frequent and prominent in visceral OvCa metastases, relative to the primary tumour and normal tissue [51] . Potentially supporting a broad role for CD36 in epithelial cancers, Pascual et al. found that CD36 expression is correlated strongly with poor survival in patients with squamous cell lung carcinoma, bladder or luminal A breast cancers [34] . In this study, high expression of CD36 characterized the head and neck cancer stem cells that drive metastasis. The metastatic potential of the subpopulation of CD36 + metastasis-initiating cells was dependent on the ability of CD36 to internalize FAs, as well as on external FAs or a high-fat diet. Inhibiting CD36 expression blocked both lymphatic and hematogenous metastasis, which together with our observations specific to the transcoelomic metastatic process, implies that CD36 has a universal role in tumour progression and metastasis [34] . Due to the multi-functional nature of the CD36 receptor and its diverse collection of ligands, we cannot exclude the possibility that mechanisms other than FA transport may be involved in its pro-tumourigenic role [52] . For example, in liver cancer, Nath et al. showed that inhibition of CD36 suppressed the epithelial−mesenchymal transition and tumourigenicity via Wnt/β -catenin and TGF-β signalling pathways [53] . Consistent with the recognized function of CD36 as a collagen receptor, we found that CD36 inhibition led to reduced adhesion on collagen I matrices [54] . This aspect of CD36 function may be of particular 
Immunoblotting
Immunoblotting was performed as previously described [8] .
The following dilutions of antibodies were used: goat anti-CD36 (AF1955, 1:1000, R&D Systems, Minneapolis, MN), mouse anti-FABPpm and rabbit anti-FATP1 (NBP1-47469, NBP1-89264 and 1:2000, Novus Biologicals, Littleton, CO), mouse anti-FATP4 (H00010999-M01, 1:1000, Abnova, Walnut, CA), mouse anti-actin (A5441, 1:5000, Sigma-Aldrich, St. Louis, MO) and rabbit anti-Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and anti p-AMPK (14C10, 1:2000 and 2535 1:1000, Cell Signaling Technology, Danvers, MA). Extraction of cytoplasmic and plasma membrane fractions was performed with a detergent-based selective extraction protocol (Mem-PER Plus Membrane Protein Extraction Kit, Pierce Biotechnology, Rockford, IL).
Quantitative real-time RT-PCR
Quantitative RT-PCR was performed using the 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA) with probes for CD36 (Hs00169627_m1, 77 bp) and GAPDH (Hs00266705_gl, 74 bp) (Applied Biosystems). Total RNA was isolated and transcribed into cDNA using a high capacity cDNA kit (Applied Biosystems). Relative levels of mRNA gene expression were calculated using the 2-ΔΔ Ct method [56] .
Immunofluorescence
Cells were plated on glass coverslips, fixed with 4% paraformaldehyde (PFA) and incubated overnight at 4°C with primary antibodies against CD36 (rabbit, HPA002018, 1:200, Sigma-Aldrich), FABPpm (mouse, 1:200, Novus Biologicals) FATP1 (mouse, 1:200, Novus Biologicals), FATP-4 (mouse, 1:200, Abnova). For plasma membrane labelling, Alexa Fluor 594 wheat germ agglutinin conjugate (W11262, Molecular Probes, Eugene, OR) was used. Samples were stained with Alexa Fluor 488 (A11059, A11001 and A11008, 1:2000, Molecular Probes) conjugated secondary antibodies. After nuclei counterstain with Hoechst, coverslips were imaged with an inverted laser scanning confocal microscope (Zeiss LSM 510 equipped with a ×63 oil immersion objective, Thornwood, NY). Z-stack confocal images were taken at 30-s intervals using AIM (version 3.2, Zeiss), and images were compiled using Zeiss LSM Image Browser (version 4.2, Zeiss). For epifluorescent microscopy, images were taken with a Zeiss Axiovert 100 microscope.
Invasion, migration and adhesion
Invasion and migration were measured using transwell chambers as previously described [55] . Briefly, 4×10 5 cells were added to the upper chamber and allowed to migrate for 12 h or invade into collagen-coated (15 μg) membranes for 24 h at 37°C. The number of migrated and invaded cells was counted in five (×200) random fields of view. Cellular adhesion was assayed in 96-well plates pre-coated with extracellular matrix proteins (5 mg/ml). Collagen I (rat tail), fibronectin and vitronectin were purchased from BD Biosciences (San Jose, CA), laminin was obtained from Millipore (Billerica, MA). Fluorescently labelled (10 mM 5-Chloromethylfluorescein Diacetate (CMFDA), Molecular Probes) cancer cells (5×10 4 cells/well) were allowed to adhere for 1 h. The number of adherent cells was determined with using a standard curve and was expressed in reference to poly-D-lysine-coated wells.
Soft agar assay
Anchorage-independent colony formation was assessed using a two-layer soft agar assay. Cells (2×10 3 ) were resuspended in culture media, mixed in with the top agar layer (0.4%) and plated over a solidified 1.5 ml nutrient feeder agar (0.8 %) underlaid in six-well plates. Plates were incubated for 21 days, after which colonies were stained with 0.005% crystal violet and counted using the GeneSys software colony-counting algorithm at medium sensitivity.
Lipid droplet accumulation
Intracellular LDs were measured using the cell permeable fluorescent lipophilic dye, BODIPY 493/503 (Molecular Probes). After overnight incubation, cells (2×10 5 ) were fixed in 4% PFA for 15 min and incubated for 10 min with 1 mg/ml BODIPY 493/503. Following nuclei counterstain with Hoechst, digital images were obtained and the ImageJ software (http://imagej.nih.gov/ij/) was used to quantify LD areas, which were normalized to the numbers of nuclei per field. Average intensities were calculated by analysing five randomly chosen fields.
Thiobarbituric acid reactive substance assay
Oxidized lipid production was assessed by measuring the formation of fluorescent MDA-TBA product (TBARS assay, Cayman Chemical, Ann Arbor, Michigan). Cells (1×10 7 ) were harvested and sonicated over ice for 15 s. After addition of Sodium Dodecyl Sulfate (SDS) and the TBA substrate, homogenates were boiled for 1 h and the reaction was stopped. After centrifugation for 10 min at 1600×g (4°C), the supernatant was transferred to a black bottom 96-well plate and fluorescence was read using a Tecan Safire2 microplate reader (excitation 530 nm/emission 550 nm) and compared to an MDA reference standard.
Total and esterified cholesterol assay
Intracellular total cholesterol content was determined with a coupled enzyme assay (EnzyChromTM AF Cholesterol Assay, Bioassay Systems, Hayward, CA) that results in a fluorometric product, proportional to the cholesterol present. 5×10 5 cells were plated in six-well plates and cellular lipid content was extracted with methanol:chloroform (1:2) using a glass homogenizer. Insoluble materials were removed with centrifugation (13,000×g for 10 min) and the organic phase was vacuum dried. Lipids were dissolved in 50 µL of the assay buffer and the cholesterol concentration was compared to a reference standard.
Fatty acid uptake
Cancer cells (2.5×10 5 ) were serum starved for 24 h and then incubated with and without adipocyte-CM for 4 h in 96-well plates. When indicated, 50 µM of the specific irreversible CD36 inhibitor, SSO (Santa Cruz Biotechnology, Dallas, TX) was added to the wells. After extracellular FAs were washed away, BODIPY-dodecanoic acid fluorescent FA analogue (BODIPY 558/568 C12) and a nontoxic cellimpermeable quenching agent, Q-Red.1 were added to the wells at the indicated time points according to the manufacturer's instructions (QBT Fatty Acid Uptake Assay Kit, Molecular Molecular Devices, Sunnyvale CA). Measurements of FA uptake were calculated from average fluorescence intensity from triplicate wells at excitation 480 nm and emission 520 nm using a Tecan Safire2 microplate reader.
Bioenergetics assay
The Seahorse XF96 Extracellular Flux Analyzer (Seahorse Biosciences, Billerica, MA) was used to obtain measurements of OCR and ECAR. OvCa cells (2.5×10 5 cells/well) were plated onto the XF96 cell plate 24 h before the assay. On the day of the assay, media were changed to assay media (serum, glucose and bicarbonate free, containing 2 mM Glutamine) or adipocyte CM, and incubated for 1 h in a non-CO 2 incubator at 37°C. 25 µl of glucose (10 mM final concentration), oligomycin (3 μM final concentration) and 2-DG (0.1 M final concentration) were added to the appropriate injection ports. For measurement of the mitochondrial capacity, drugs were injected to the final concentration as 2 μg/ml of oligomycin, 2.5 μM of carbonyl cyanide-p trifluoromethoxyphenylhydrazone and 2 μM of antimycin A.
Xenograft model
All animal experiments were approved by the Institutional Animal Care and Use Committee and were in accordance with the University of Chicago's policies on the care, welfare and treatment of laboratory animals. SKOV3ip1 cells (1×10 6) and OVCAR-8 cells (5×10 6 ) were injected intraperitoneally into 7-week-old female athymic nude mice (Harlan Teklad, Indianapolis, IN). Mice were randomly assigned into experimental or control groups, blinding was not possible. Group size was determined based on the results of pilot studies; all animals were included in the analysis. In the CD36 shRNA experiment (n = 8 mice per group), 32 days after injection the mice were killed and the tumour colonies were counted, collected and weighed. In the anti-CD36 antibody experiment (n = 5 mice per group), 1 week following tumour inoculation, intraperitoneal daily treatment with 10 μg anti-CD36 monoclonal antibody (mouse, JC63.1, Cayman Chemical, Ann Arbor, MI) or the IgA isotype control (mouse, ab37322, Abcam) was initiated and continued for 4 weeks. All antibodies were azide-free with no added preservatives. Excised tumour tissues were stained with H&E, Masson's trichrome or incubated with antibodies against Ki-67 (RM-9106-S0, Thermo Scientific, Waltham, MA), CD31 (ab28364, Abcam), Anti-Carbonic Anhydrase IX (CA IX, ab 15086, Abcam) and Fibronectin (F3648, Sigma-Aldrich). Protein detection was completed using the Vectastain ABC Kit (Vector Laboratories, Burlingame, CA). For determination of apoptosis, the ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit (Millipore) was used. Images were taken using the AxioVision imaging system in five random fields per sample at ×200 magnification and analysed using the ImageJ software. For determination of Ki67 and TUNEL staining, the number of positive cells was recorded as a percentage of the total number of cells within a field of view. For MVD, the average number of positively stained (CD31+) blood vessels per field of view was counted. Tumour hypoxia was quantified by adding the CA IX staining intensity scores (1 = weak or undetectable, 2 = moderate, 3 = strong staining) and the percentage scores of stained tumour cells (1 = <5%, 2 = 5-50%, 3 = >50% positive cells). Only a membranous staining pattern was considered positive. Quantification of fibronectin protein expression and collagen content was performed using Aperio ImageScope and Spectrum software as described previously [57] .
Human tissue samples
After obtaining an informed consent human omentum and tumour samples were collected from patients undergoing surgery at the University of Chicago. All specimens were obtained in accordance with a protocol approved by the Institutional Review Board (IRB). Cryosections from ten fresh frozen high-grade serous primary ovarian tumours and their corresponding omental metastasis were mounted on nuclease free polyethylene naphthalate (PEN)-membrane covered slides (Zeiss MicroImaging). Slides were stained and evaluated by a gynaecologic oncology pathologist. Tumour cells were microdissected into microcentrifuge caps (AdhesiveCaps, Zeiss MicroImaging) with a pulsed low heat ultraviolet-A (337 nm nitrogen) laser microscope system (PALM MicroBeam, P.A.L.M. Microlaser Technologies GmbH, Bernried, Germany). Total RNA was harvested with the RNeasy ® Micro Kit (Qiagen, Valencia, CA) and concentration and purity was tested with a spectrophotometer.
Proliferation
The proliferation of OvCa cells was measured using the CyQuant cell proliferation assay kit as described previously [55] .
Short hairpin RNA CD36 targeting
Knockdown of CD36 was achieved through the use of pLKO.1-puro shRNA lentiviral transduction particles obtained from the MissionTM shRNA library (Sigma-Aldrich).
Five different shRNA constructs (TRCN0000056998-TRCN0000057002) were tested together with a non-targeting (scrambled) shRNA (SHC002) control. In brief, cells were plated in 96-well plates (1×10 4 / well) and were incubated overnight with the appropriate lentiviral particles (MOI = 5) in the presence of hexadimethrine bromide (final concentration: 10 µg/ml). Cells were then selected with 0.5 μg/ml puromycin for 2 weeks and resistant colonies were picked, expanded and assayed for knockdown efficiency.
Oligonucletodie microarray analysis
Total RNA was isolated using the RNeasy Mini kit and RNase-free DNase Set (Qiagen) [58] . RNA quality and integrity were determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA). Biotinylated cRNA was prepared using the Illumina TotalPrep RNA Amplification Kit (Ambion, Inc., Austin, TX), starting with 200 ng total RNA. Biotin-labelled cRNA (750 ng) from three biological replicates was hybridized to an Illumina HumanHT-12_V4 Expression BeadChip microarray (Illumina, San Diego, CA) at the University of Chicago Functional Genomics Core Facility. Arrays were scanned on an Illumina's BeadStation 500GX Genetic Analysis System. Data were extracted using GenomeStudio Software (v2011.1, Illumina) and the raw probe intensities were background subtracted, log 2 transformed and Quantile normalized. ANOVA and multiple testing corrections were used to detect DEGs. Fold change was calculated by the average log 2 expression differences and were considered significant at p < 0.05, fold change ≥ 2, with a false discovery rate of 5% or less. Volcano plots were generated in R with the use of Student's t-test and generic plot function. The array data have been deposited in Gene Expression Omnibus (GEO; accession number GSE104237).
